Individual and group level factors associated with the probability of antimicrobial resistance of uropathogenic Escherichia coli were analysed in a multilevel model.
Introduction
Urinary tract infection (UTI) is the second most common bacterial infection in general practice. 1 Empirical treatment with antimicrobials is routine practice. 2 Acquired antimicrobial resistance is an increasingly serious problem which limits options for effective treatment of bacterial infections with antimicrobials. Antimicrobial prescribing at both the individual patient level and at practice or area level has been shown to contribute to the antimicrobial resistance of bacteria isolated from patients with UTI. 3 -6 The evidence for a direct link between individual patient prescribing and infection with resistant bacteria is strong. 7 However, evidence of the impact of area or practice mainly originates from ecological studies, where country or area prescribing and resistance levels obtained from surveillance systems were found to be associated. 8, 9 The aim of the study was to examine the individual (patient) and group (practice) level factors associated with the probability of isolation of antimicrobial-resistant Escherichia coli from patients with UTI by means of multilevel statistical modelling. This statistical modelling was expected to estimate the relative importance of individual-and higher-level factors influencing the probability of isolation of an antimicrobial-resistant E. coli compared with a susceptible E. coli. Additionally, to evaluate evidence for transmission of uropathogenic E. coli isolates in the community the relatedness of samples from two geographically close practices was analysed using PFGE.
The present paper applies multilevel modelling in a study on antimicrobial resistance. It is accompanied by a stand-alone paper, 'Principles of multilevel analysis and its relevance to studies of antimicrobial resistance', 10 to give readers a better understanding of the methods used in this analysis.
Methods

Study design and population
This study was part of an ongoing project on antimicrobial resistance and UTI in general practice and received ethical approval from the Irish College of General Practitioners. 11 A prospective case-control study was set up in 22 participating practices in the west of Ireland and ran over a period of 9 months (September 2009 -May 2010). All adult patients (18 and over) visiting a participating practice with a suspected UTI were requested to supply a urine sample. Upon receipt of the urine sample in the laboratory, a letter was sent to the patient describing the study and including an opt-out form. Patients could opt out of the study by sending back the opt-out form (freepost), filling in the opt-out form on a dedicated web site (www.antibiotics.nuigalway.ie) or by telephone. Participating practices were visited and the medical files of the patients were viewed for information on antimicrobial use in the previous year, previous urine samples submitted and demographic information. All data recording was performed by one investigator, blind to the outcome, to ensure data quality as well as confidentiality. Patients with indwelling catheters and pregnant women were excluded from the study. More information and background on this study was published in two previous papers. 12, 13 Microbiology was performed at the Department of Medical Microbiology, Galway University Hospital, which is an accredited diagnostic laboratory (ISO 15189). All urine samples with laboratory-confirmed E. coli isolates (colony count .10 5 cfu/mL) were included. Only the first E. coli isolate from each patient during the study period was included in this analysis. Antimicrobial susceptibility testing was performed by disc diffusion according to CLSI methods.
14 Susceptibility to the following agents was assessed: ampicillin, co-amoxiclav, trimethoprim, ciprofloxacin and nitrofurantoin.
Two out of the 22 participating practices were selected for further analysis of the relatedness of E. coli, based on their high number of submitted urine samples as well as their geographical proximity. PFGE was carried out on all E. coli isolates following the standardized PulseNet system developed by the CDC, Atlanta, GA, USA.
15 E. coli isolates were compared using BioNumerics, producing dendrograms showing the relatedness of isolates. Isolates were considered related if .85% similar. 16 For statistical analysis, E. coli isolates classified as 'intermediate' were categorized as resistant. Cases were patients with an antimicrobialresistant E. coli UTI, controls were patients with an antimicrobialsusceptible E. coli UTI.
Sample size
Sample size calculations were based on the prevalence of trimethoprim resistance and trimethoprim prescription data from a previous retrospective multilevel study. 11 A difference between exposure to trimethoprim in cases versus controls of 10 percentage points was considered important (30% of the cases and 20% of the controls had trimethoprim exposure in the previous year). A total of 216 cases would be necessary to reject the null hypothesis that the exposure rates for cases and controls are equal with 80% power and 5% two-sided a. A design effect adjusting for the clustering of data, of 1.29 for a mean of 30 patients per cluster, was calculated [intra-class correlation (ICC) 1%] resulting in an anticipated recruitment of 278 cases or a total of 556 patients.
Data analysis
Individual-level variables
At the patient level, data were collected on previous antimicrobial prescriptions up to a year prior to the first sample submitted during the study period. Any antimicrobial prescribed during this period was recorded according to the major antimicrobial group: penicillins, b-lactam/b-lactamase inhibitor combinations (co-amoxiclav mainly), trimethoprim, fluoroquinolones, cephalosporins and other antimicrobials. The fluoroquinolones recorded were mainly ciprofloxacin and occasionally ofloxacin. To increase the readability of this paper, prescriptions from this antimicrobial group will be referred to as ciprofloxacin prescribing. For univariate analysis, prescribing in the previous year was dichotomized (yes/no). For multilevel analysis, the number of prescriptions of antimicrobials in the previous year was included as a categorical variable: no prescriptions, one prescription, two prescriptions and three or more prescriptions. For ciprofloxacin the highest two categories were collapsed into two or more prescriptions in the previous year. From the laboratory system, age, gender and nursing home residence of the patients were available. Additional data were collected from the individual charts on previous urine samples, medical card status, number of general practitioner (GP) visits in the previous year (. 10 or ,10), number of urine samples in the previous year and other prescriptions, categorized as medication for asthma, diabetes, thyroid, cardiovascular or circulatory medication, mood-altering and sleep medication or any other medication. Age was centred around the general mean age. Medical card eligibility depends on income and age and can be interpreted as a proxy measure of socio-economic status. A medical card gives the individual access to free medical care and medication. At the time of the study about one-third of the population possessed a medical card. Hospitalization was recorded from the GP charts and checked with the hospital patient administration system of the main hospital for the area.
Group-level variables
The study included data on 22 practices of various sizes. The number of urine samples included for each practice over the study period was included as a variable. For each practice prescription rates were calculated based on (i) data obtained from the Health Service Executive Primary Care Reimbursement Scheme (HSE-PCRS), which records all prescriptions for medical card patients, and (ii) data collected during a previous study on the management of UTI in general practice (including all suspected UTIs over a period of 2 months). A practice resistance level was calculated from retrospective laboratory data for the year prior to the start of the prospective study (September 2008 to August 2009) as a proxy for exposure to practice-level resistance.
Statistical analysis
Univariate analysis (PASW version 18.0) was performed to compare demographic variables and antimicrobial prescribing between individuals with a susceptible isolate and individuals with a resistant isolate. Antimicrobial prescribing in the previous year was dichotomized (yes/no) so that ORs could be generated. Unadjusted associations were calculated and variables significant at a P value of ,0.1 were included in subsequent multilevel analysis.
A multilevel logistic regression analysis was used to estimate the odds of patients with an E. coli UTI that is resistant, allowing for the hierarchical structure of the data (patients nested within practices). The model building used a forward stepwise selection process. The 'empty' model, including only the random parameter, was calculated to partition the variance at the two levels by calculating the variance partition coefficient (VPC). 17 The VPC is the proportion of the total variance of the outcome that is explained at the higher practice level and therefore represents the heterogeneity between the practices. Individual-and then practicelevel variables were introduced into the empty model. Cross-level and intra-level interactions were checked for significance. Models were compared using the deviance information criterion (DIC), which combines the deviance with information about the number of parameters in the model.
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To avoid collinearity, variables that were closely correlated were separately introduced in each model and only the most significant variable was retained [e.g. hospitalization in the previous year and emergency department admission/medical card status and number of visits in the previous year/medical card status (medical card or private patients) and prescriptions for other illnesses].
The percentage of proportional change in variance (PCV) was calculated, representing the percentage of variation explained by the variables in the model compared with the empty model.
The adjusted ORs with 95% CIs for resistance to the antimicrobial agents were calculated for the fixed effects. In order to quantify the variability between practices in antimicrobial resistance level, a median OR (mOR) was calculated using Larsen's mOR. 18, 19 An mOR equal to 1 signifies no differences between practices in the probability of an antimicrobial-resistant E. coli. For the mOR a Bayesian credible interval (CrI) was calculated based on the distribution of the mOR to distinguish it from a fixed-effects OR CI.
To optimize comparison, a final model was built for the outcome resistance to the particular antimicrobial using the same variables, irrespective of their significance. Parameters were estimated by Markov chain Monte Carlo (MCMC) methods in the MLwiN version 2.21 software. 20, 21 A P value ,0.05 was considered significant.
Results
Practices and participants
The 22 practices submitted between 6 and 58 E. coli-positive urines. The number of antimicrobial prescriptions per practice ranged from 28 to 171, with a mean of 129. The mean practice resistance over the previous 12 months was 8% for ciprofloxacin and 31% for trimethoprim (Table 1) . Over the 9 month period, 633 patients with a laboratory-confirmed E. coli UTI and a full record for all variables were included ( Table 2) . Of the E. coli isolates, 36% were resistant to trimethoprim and 12% to ciprofloxacin. Overall, 66.1% of the patients had at least one antimicrobial prescribed in the year prior to this episode of UTI; 14.7% had at least one prescription for ciprofloxacin and 20.5% for trimethoprim.
Univariate analysis
Patients with a medical card represented 61% of this group, and the proportion of E. coli resistant to ciprofloxacin or trimethoprim was significantly higher in medical card patients compared with private patients for both antimicrobials. Similarly, increasing age, increasing number of antimicrobial prescriptions, nursing home residence, prescription for other conditions, in particular patients receiving cardiovascular medication, and number of visits in the previous year were associated with a greater odds of a resistant E. coli compared with susceptible E. coli. Male gender and hospitalization in the previous year had a significantly higher OR for patients with a ciprofloxacin-resistant E. coli compared with susceptible E. coli. An overview of the patient and practice characteristics and univariate analysis is presented in Table 2 .
Multilevel modelling
The final model was generated including age, male gender, nursing home residence, hospitalization in the previous year, medical card eligibility, prescriptions for other conditions and antimicrobial prescribing in the previous year at the patient level (Table 3) . At practice level the percentage antimicrobial prescribing of the respective agents per month was included even though this model was only slightly better compared with the model with practice resistance levels and neither practice-level variable reached significance. The odds that an E. coli was resistant increased with an increasing number of prescriptions over the previous year. For ciprofloxacin the ORs were 2.7 (1.2 -5.6) for one and 6.5 (2.9 -14.8) for two or more ciprofloxacin prescriptions in the previous year. This effect only became significant after at least two trimethoprim prescriptions in the previous year, with an OR of 4.7 (1.9 -12.4) for two prescriptions and 6.4 (2.0-25.4) for three or more trimethoprim prescriptions per year. For both antimicrobials the trend that an E. coli was resistant with increased previous prescribing, tested significant. Figure 1 shows a graph of the predicted probability (and prediction interval) that an E. coli was resistant with increasing number of prescriptions.
Age was a significant factor in the odds of a resistant E. coli. Male gender, hospitalization and medical card status were not significant for either antimicrobial in the odds of a resistant E. coli after correction for the other factors. Nursing home residence was a significant factor for ciprofloxacin resistance (Figure 2) , with a 3-fold increase in OR, but this was not found for trimethoprim.
The cluster effect calculated in the VPC was relatively small for trimethoprim and larger for ciprofloxacin, which means that the inter-cluster effect (difference between practices) was relatively more important for ciprofloxacin while the intra-cluster effect (individual factors) was relatively more important for trimethoprim. A caterpillar plot showing the estimated residuals for all the practices in rank order was made based on the final model ( Figure 3) . The horizontal line at zero shows the average resistance at practice level. The practice-level residuals were greater for ciprofloxacin, which showed the higher variability in antimicrobial resistance between practices for ciprofloxacin compared with trimethoprim.
The cluster effect or practice-level variance is also reflected in the mOR; the higher the mOR, the more important the difference between practices. The mOR for trimethoprim was 1.17 (CrI 1.03-1.46) and the mOR for ciprofloxacin was 1.33 (CrI 1.03-1.90), which can be interpreted as a risk increase of 17% for trimethoprim and 33% for ciprofloxacin that an E. coli would have been resistant had the patient consulted in another practice with A multilevel analysis of antimicrobial prescribing and resistance in UTI 2525 JAC higher risk. Comparing the relevance of variables for the understanding of variations in the odds of a resistant E. coli, the impact of the person's previous prescriptions was of highest relevance, but the variation between practices was also important. The decrease in mOR from the empty to the full model for ciprofloxacin suggests that the practice variance was due to practicelevel variables and not due to a different individual composition of the practice. For trimethoprim no difference between the empty model and the final model was observed, indicating that the (small) variance observed between practices was not due to differences in the introduced individual-or practice-level variables.
A number of additional analyses were performed. Firstly, excluding the extended-spectrum b-lactamases (ESBLs) from the multilevel analysis resulted in nursing home residence losing significance in the ciprofloxacin model. Trimethoprim resistance was not significantly affected by nursing home residence in either model. Secondly, a trimethoprim resistance model was run replacing trimethoprim prescribing with the combination of ampicillin and trimethoprim prescription in the previous year, but this did not improve the model. Thirdly, differences in hospitalization with and without emergency admission and outpatient visits were compared as well as the period of admission (1 year or 6 months). No important differences were observed.
Relatedness of E. coli isolates
A total of 104 E. coli urine isolates from two selected practices were evaluated using PFGE to evaluate similarity of E. coli isolates within and between practices. The dendrogram of isolates showed 20 clusters of two or more isolates with .85% homology. There were four pairs of indistinguishable isolates: two pairs in one practice, one in the other practice and one pair including an isolate from each of the two practices. The general practices were in the same geographical area, but patients would generally not be shared.
Discussion
The main findings of this study were that increasing prescribing increased the individual odds that an E. coli isolated from a UTI was resistant and the importance of the practice in this Vellinga et al.
probability. The increasing ORs with an increasing number of antimicrobial prescriptions supports the causality principle of dose-response relation. The large OR for trimethoprim after two previous prescriptions and even more so for ciprofloxacin after only one previous prescription, warrants prudent use of these antimicrobials. It should also be noted that the data analysis did not differentiate between the types of infection for which the antimicrobial was prescribed, which was important for ciprofloxacin in particular as this agent (or closely related fluoroquinolone agents) is also prescribed for respiratory infections.
Another variable significant in the model was nursing home residence in the ciprofloxacin model. The increased odds for nursing home residence were associated with the higher prevalence of ESBL infections in nursing homes. The problem of nursing homes as a reservoir for these highly resistant E. coli Figure 2 . Predicted probability of a ciprofloxacin-resistant E. coli for patients in the community or in a nursing home.
A multilevel analysis of antimicrobial prescribing and resistance in UTI 2527 JAC has been described previously. 22 This paper also reported that increased ciprofloxacin use and UTI infections were independent risk factors associated with increased ESBL carriage. The finding that all other factors (except age) were found not significant shows that the odds that an E. coli is resistant is mainly driven by previous individual prescribing and practice-related factors.
This analysis allows for the clustering of the data at practice level, which was shown to be of importance in a previously published paper. 11 Even though the clustering was quantified as substantial in the mOR, this practice-level variation in the outcome could not be explained by either practice prescribing or practice resistance levels. A multilevel analysis of retrospective data including practice prescribing instead of the individual prescribing showed similar results for practice-level variation. This suggests that, with only the individual prescribing significant in the prospective model, it is not practice-level prescribing (or resistance) conveying the practice probability of a resistant E. coli. A critical point in multilevel analysis is the level at which data were aggregated, which was at the practice level in our study. For an individual the limits that define the human body are obvious; the boundaries of geographical environments are, however, less obviously delineated. 23, 24 The validity of administrative boundaries in the study of antimicrobial resistance could be criticized, and even though the practice level was a convenient measure to aggregate data, this did not seem to be supported by the results of the analysis, resulting in relatively small measures of association (ICC). The PFGE results supplied additional information by identifying 20 clusters of two or more isolates with .85% homology, including 4 pairs of indistinguishable isolates with one of these from patients from both practices. This is a limited subset of isolates from the study, but indicates that transmission of uropathogenic E. coli from person to person in the community may occur and also suggests that this transmission is not constrained within the boundaries of the practice the patient visits. The reason why practice-level variables could not explain any of the variation may be because the practice level is not the most appropriate boundary for a level, and even though the practice is a very practical boundary a higher level transcending the practice might influence the probability of a resistant E. coli.
Currently, a follow-up study is under way in which the impact of prescribing at individual and practice levels is the focus. This Interdisciplinary Capacity Enhancement grant (Health Research Board Ireland) aims to set up an intervention in which various aspects of prescribing are addressed. The potential of this grant in combining epidemiology, microbiology, social marketing, statistical and health economic applications will add to our understanding of the complex problem of antimicrobial resistance.
Limitations of the study
The main limitation of the study lies in the limited number of practices and the relatively low cluster size. It has been shown that small group size may lead to a type II error while the fixed-effect parameters were unbiased. 25, 26 Publication of our data might urge other research groups to share their data with the aim of increasing the overall sample size. Additionally, as the mOR is time-and place-specific, 27 the importance of practice-level variation can be further analysed by the inclusion of data from other centres.
Selection bias threatens the validity of many epidemiological studies. In our study, however, we do not expect a selection bias to be of importance as an opt-out methodology was used for the inclusion of patients. We showed that the use of this methodology resulted in an opt-out of 14% and that there was no difference in opt-out between patients with and without an organism isolated from their urine sample. 12 Practice variation is a common phenomenon that may reflect different therapeutic approaches to a similar health problem or may reflect an underlying, possible geographical trait. 28 -30 Even though our multilevel approach controlled for confounding by including practice-and patient-level factors, none of the included factors at the practice level could explain the variation between practices. The characterization of these unidentified factors is needed to understand the occurrence and spread of resistance as well as to design appropriate interventions. However, it is clear that prudent prescribing of trimethoprim and ciprofloxacin to individual patients is important as it is highly associated with their probability of a resistant E. coli as a cause of UTI.
The potential of molecular typing to assist in assessing evidence of transmission between patients within practices and between different practices was limited by the small number of isolates included. Typing of a larger number of isolates from a series of practices over an extended period of time may be helpful in clarifying the extent and routes of transmission of uropathogenic E. coli.
How this compares with other literature
Most papers include the time since the last prescription of the antimicrobial in their analysis and generally show higher ORs for prescriptions given closer to the episode. 4, 6 None of these studies looked at previous ciprofloxacin use. For trimethoprim, increased previous prescribing of trimethoprim and subsequent resistance was also identified by Hillier et al., 6 who found an association between number of courses of trimethoprim and resistance, even though they did not find a significant trend [OR 2.08 (1.34 -3.22) for one dose, 2.05 (0.85 -4.94) for two doses and 7.53 (2.71 -20.88) for three or more doses]. The sample size in this study was comparable to ours, but the prevalence of trimethoprim resistance in our study was higher (17% versus Vellinga et al.
36% in our study), which might explain the lack of a significant trend. Metlay et al. 31 also found a strong relationship between the number of any antimicrobial courses received in the preceding 6 months and the likelihood of a trimethoprim/ sulfamethoxazole-resistant UTI in male veterans, but not for other antimicrobials. Hay et al. 32 did not find an increase in resistance with increasing previous courses, but found an increase of 1% in the odds of resistance for every trimethoprim tablet prescribed. Even though some of these studies included practice variables, all data were analysed at the individual level only and none of the analyses allowed for the cluster effect by separating the practice and individual levels.
A study specifically identifying the endemic lineages of E. coli that cause UTIs found clustering of E. coli clonal groups causing community-acquired UTI in unrelated women in two locations and at two different timepoints, and they suggested point source dissemination. 33 The lack of information on the possible transmission routes, similar to our study, led them to speculate that, due to the number, timing and geographical spread of the locations, the most probable route would be food related. Direct person-to-person or household transmission is also plausible in the context of our study of patients living in geographical proximity. More research is necessary to identify the possible source and transmission routes.
To our knowledge, no other study has simultaneously included practice-and individual-level prescribing in the analysis of individual-level resistance data. Studies analysing individual resistance data include either individual prescribing of an antimicrobial agent or practice (area) prescribing. 3, 4, 6, 31, 32, 34, 35 Our study shows that when previous practice prescribing as well as previous individual prescribing is included, only the individual prescribing is a significant predictor of a UTI with a resistant E. coli. More studies are necessary to confirm our findings. However, if our findings can be replicated in other studies and other areas, this may also help to identify other factors that are of importance in explaining higher-level variance.
